Tan Q, Li F, Wang J, Zou Y, Tang Y, Cai Y
J Cancer. 2025; 16(3):750-764.
PMID: 39781344
PMC: 11705044.
DOI: 10.7150/jca.101050.
Lun Y, Sun J, Wei L, Liu B, Li Z, Dong W
Cell Death Dis. 2024; 15(11):822.
PMID: 39537605
PMC: 11561306.
DOI: 10.1038/s41419-024-07214-3.
Zhu L, Duan W, Peng L, Shan X, Liu Y, Huang Z
Heliyon. 2024; 10(19):e37897.
PMID: 39386833
PMC: 11462186.
DOI: 10.1016/j.heliyon.2024.e37897.
Feroz W, Park B, Siripurapu M, Ntim N, Kilroy M, Sheikh A
Int J Mol Sci. 2024; 25(17).
PMID: 39273383
PMC: 11395477.
DOI: 10.3390/ijms25179435.
Chen Y, Lin T, Tang L, He L, He Y
Am J Cancer Res. 2024; 13(12):5805-5824.
PMID: 38187072
PMC: 10767356.
Molecular mechanism underlying epithelial-mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma.
Song K, Ma C, Gu B, Wang B, Ma H, Deng X
Thorac Cancer. 2023; 14(31):3069-3079.
PMID: 37718469
PMC: 10626249.
DOI: 10.1111/1759-7714.15094.
The Critical Function of microRNAs in Developing Resistance against 5- Fluorouracil in Cancer Cells.
Sheikhnia F, Maghsoudi H, Majidinia M
Mini Rev Med Chem. 2023; 24(6):601-617.
PMID: 37642002
DOI: 10.2174/1389557523666230825144150.
m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway.
Lin K, Zhou E, Shi T, Zhang S, Zhang J, Zheng Z
J Exp Clin Cancer Res. 2023; 42(1):217.
PMID: 37605223
PMC: 10464189.
DOI: 10.1186/s13046-023-02792-0.
METTL3 Mediates Epithelial-Mesenchymal Transition by Modulating FOXO1 mRNA N -Methyladenosine-Dependent YTHDF2 Binding: A Novel Mechanism of Radiation-Induced Lung Injury.
Feng Y, Yuan P, Guo H, Gu L, Yang Z, Wang J
Adv Sci (Weinh). 2023; 10(17):e2204784.
PMID: 37072646
PMC: 10265050.
DOI: 10.1002/advs.202204784.
MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance.
Liu L, Chen C, Liu P, Li J, Pang Z, Zhu J
Adv Sci (Weinh). 2023; 10(14):e2203423.
PMID: 36929633
PMC: 10190571.
DOI: 10.1002/advs.202203423.
miR-26b Targets CEP135 Gene to Regulate Nasopharyngeal Carcinoma Proliferation and Migration by NF-κB Pathway.
Yang G, Zhou J, Guo Z, Fan L, Chen B, Zhang D
Mol Biotechnol. 2023; 65(11):1857-1868.
PMID: 36820950
PMC: 10518290.
DOI: 10.1007/s12033-023-00691-5.
Differences in expression of genes related to drug resistance and miRNAs regulating their expression in skin fibroblasts exposed to adalimumab and cyclosporine A.
Grabarek B, Schweizer P, Adwent I, Wcislo-Dziadecka D, Krzaczynski J, Kruszniewska-Rajs C
Postepy Dermatol Alergol. 2023; 38(2):249-255.
PMID: 36751547
PMC: 9880787.
DOI: 10.5114/ada.2019.91506.
Modulating Effects of Cancer-Derived Exosomal miRNAs and Exosomal Processing by Natural Products.
Chuang Y, Tang J, Shiau J, Yen C, Chang F, Yang K
Cancers (Basel). 2023; 15(1).
PMID: 36612314
PMC: 9818271.
DOI: 10.3390/cancers15010318.
The roles of CPSF6 in proliferation, apoptosis and tumorigenicity of lung adenocarcinoma.
Zu Y, Wang D, Ping W, Sun W
Aging (Albany NY). 2022; 14(22):9300-9316.
PMID: 36446361
PMC: 9740356.
DOI: 10.18632/aging.204407.
Insight into LncRNA- and CircRNA-Mediated CeRNAs: Regulatory Network and Implications in Nasopharyngeal Carcinoma-A Narrative Literature Review.
Zhang S, Li Y, Xin S, Yang L, Jiang M, Xin Y
Cancers (Basel). 2022; 14(19).
PMID: 36230487
PMC: 9559536.
DOI: 10.3390/cancers14194564.
Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma.
Li H, Deng N, He X, Li Y
Biomark Res. 2022; 10(1):52.
PMID: 35883139
PMC: 9327212.
DOI: 10.1186/s40364-022-00397-x.
Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors.
Xu L, Zou C, Zhang S, Chu T, Zhang Y, Chen W
J Hematol Oncol. 2022; 15(1):87.
PMID: 35799264
PMC: 9264569.
DOI: 10.1186/s13045-022-01307-2.
Nasopharyngeal carcinoma related miRNA detection through a DSN enzyme assisted tetrahedral probe for more accurate prognosis.
Zhang L, Lou Z
RSC Adv. 2022; 11(19):11398-11402.
PMID: 35423657
PMC: 8695942.
DOI: 10.1039/d1ra00539a.
Radiosensitizer EXO-miR-197-3p Inhibits Nasopharyngeal Carcinoma Progression and Radioresistance by Regulating the AKT/mTOR Axis and HSPA5-mediated Autophagy.
Jiang J, Tang Q, Gong J, Jiang W, Chen Y, Zhou Q
Int J Biol Sci. 2022; 18(5):1878-1895.
PMID: 35342334
PMC: 8935226.
DOI: 10.7150/ijbs.69934.
Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer.
Liu L, Lv J, Lin Z, Ning Y, Li J, Liu P
Front Mol Biosci. 2022; 8:785922.
PMID: 35223984
PMC: 8864135.
DOI: 10.3389/fmolb.2021.785922.